Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi

Sponsor
Northwestern University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05646069
Collaborator
(none)
6
1
3
12
0.5

Study Details

Study Description

Brief Summary

This study is designed to provide an evaluation of currently available disposable flexible ureteroscopes in real-world conditions. Due to high re-processing costs associated with re-usable flexible ureteroscopes, there has been a demand for Urologic device manufacturers to provide single-use flexible ureteroscopes.

Condition or Disease Intervention/Treatment Phase
  • Device: Storz Flex-XC1 Disposable Flexible Ureteroscope
  • Device: Storz Flexible Digital Ureteroscope
N/A

Detailed Description

Patients randomized to the experimental group will receive flexible ureteroscopy with the Storz Flex-XC1 disposable flexible ureteroscope.

Data will be collected and stored electronically in REDCap. Quality assurance steps will include testing of the database, including any potential data calculated by command functions within REDCap

Scope performance survey will be administered with REDcap.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
AssignmentAssignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi
Actual Study Start Date :
Nov 15, 2022
Anticipated Primary Completion Date :
Nov 15, 2023
Anticipated Study Completion Date :
Nov 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Storz Flex-XC1 disposable flexible ureteroscope

A patient is randomized to the experimental arm using the Storz Flex-XC1 disposable flexible ureteroscope.

Device: Storz Flex-XC1 Disposable Flexible Ureteroscope
Patients will receive flexible ureteroscopy with the Storz Flex-XC1 disposable flexible ureteroscope.

No Intervention: Analogue scope

A patient is not randomized to the experimental arm using the Storz Flex-XC1 disposable flexible ureteroscope.

Experimental: Digital ureteroscope

A patient is randomized to the experimental arm using a Digital ureteroscope.

Device: Storz Flexible Digital Ureteroscope
Patients will receive flexible ureteroscopy with the Storz flexible Digital ureteroscope.

Outcome Measures

Primary Outcome Measures

  1. Scope performance [0-1 day]

    Difference in scope performance grading by multiple blinded reviewers

Secondary Outcome Measures

  1. Operating room outcomes [0-1 day]

    The difference in operating room outcomes: basketing time

  2. Operating room outcomes [0-1 day]

    The difference in operating room outcomes: scope setup time

  3. Operating room outcomes [0-1 day]

    The difference in operating room outcomes: laser-use time

  4. Operating room outcomes [0-1 day]

    The difference in operating room outcomes: operative time

  5. Operating room outcomes [0-1 day]

    The difference in operating room outcomes: number of flexible ureteroscopes used

  6. Post-operative outcomes [4-6 weeks]

    The difference in postoperative outcomes using a questionnaire: the patient has a UTI

  7. Post-operative outcomes [4-6 weeks]

    The difference in postoperative outcomes using a questionnaire: the patient is stone-free

  8. Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: visual quality (resolution) [4-6 weeks]

    Post-operative, the surgeon will watch videos of each surgery to analyze the satisfaction of the flexible ureteroscope (graded on a scale of 1-5)

  9. Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: visual quality (color) [4-6 weeks]

    Post-operative, the surgeon will watch videos of each surgery to analyze the satisfaction of the flexible ureteroscope (graded on a scale of 1-5)

  10. Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: color interference [4-6 weeks]

    Post-operative, the surgeon will watch videos of each surgery to analyze the satisfaction of the flexible ureteroscope (graded on a scale of 1-5)

  11. Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: laser interference [4-6 weeks]

    Post-operative, the surgeon will watch videos of each surgery to analyze the satisfaction of the flexible ureteroscope (graded on a scale of 1-5)

  12. Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: field of view [4-6 weeks]

    Post-operative, the surgeon will watch videos of each surgery to analyze the satisfaction of the flexible ureteroscope (graded on a scale of 1-5)

  13. Post-operative surgery satisfaction of the flexible utereoscope using a questionnaire: overall impression [4-6 weeks]

    Post-operative, the surgeon will watch videos of each surgery to analyze the satisfaction of the flexible ureteroscope (graded on a scale of 1-5)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Males and Females 18-89 undergoing ureteroscopy for laser treatment of renal calculi

  • Willing to sign the Informed Consent Form

  • Able to read, understand, and complete patient questionnaires, pain texts, and medication diary.

Exclusion Criteria:
  • Patients having a concomitant procedure along with ureteroscopy (example: contralateral PCNL)

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwestern University Chicago Illinois United States 60611

Sponsors and Collaborators

  • Northwestern University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amy Krambeck, Professor of Urology, Northwestern University
ClinicalTrials.gov Identifier:
NCT05646069
Other Study ID Numbers:
  • STU00217933
First Posted:
Dec 12, 2022
Last Update Posted:
Dec 12, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 12, 2022